Atlas Trials

The First People's Hospital of Changzhou

28 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch The First People's Hospital of Changzhou

RecordFirmDate
Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy (NCT07769671)The First People's Hospital of Changzhou2026-09-01
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis (NCT06867991)The First People's Hospital of Changzhou2024-11-08
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC (NCT06456515)The First People's Hospital of Changzhou2024-05-01
Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in Patients With Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multi-center, Randomized Comparison (NCT06950242)The First People's Hospital of Changzhou2024-04-11
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes (NCT06216340)The First People's Hospital of Changzhou2024-02-15
Wingspan Stent System for Intracranial Artery Stenosis (NCT06618222)The First People's Hospital of Changzhou2023-10-17
SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC (NCT05732662)The First People's Hospital of Changzhou2023-04-01
Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer (NCT02491697)The First People's Hospital of Changzhou2016-02-01
CIK in Treating Patients With Bladder Cancer (NCT02489890)The First People's Hospital of Changzhou2016-02-01
Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer (NCT02496273)The First People's Hospital of Changzhou2016-01-01
CIK in Treating Patients With Esophageal Cancer (NCT02490735)The First People's Hospital of Changzhou2015-08-01
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating (NCT02487550)The First People's Hospital of Changzhou2015-08-01
Cytokine-induced Killer Study for Patients With Stage II Melanoma (NCT02498756)The First People's Hospital of Changzhou2015-08-01
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR (NCT02493582)The First People's Hospital of Changzhou2015-07-01
Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas (NCT02494804)The First People's Hospital of Changzhou2015-07-01
Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas (NCT02496988)The First People's Hospital of Changzhou2015-07-01
The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer (NCT02487992)The First People's Hospital of Changzhou2015-07-01
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer (NCT02490748)The First People's Hospital of Changzhou2015-07-01
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma (NCT02487693)The First People's Hospital of Changzhou2015-07-01
Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma (NCT02497898)The First People's Hospital of Changzhou2015-07-01
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer (NCT02485015)The First People's Hospital of Changzhou2015-06-01
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer (NCT02870153)The First People's Hospital of Changzhou2013-01-01
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma (NCT02482454)The First People's Hospital of Changzhou2012-07-01
TOF Versus SOX in Metastatic Gastric Cancer (NCT02442362)The First People's Hospital of Changzhou2012-01-01
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer (NCT02502630)The First People's Hospital of Changzhou2010-06-01
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases (NCT02419677)The First People's Hospital of Changzhou2010-01-01
Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer (NCT02423226)The First People's Hospital of Changzhou2008-10-01
Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer (NCT02475889)The First People's Hospital of Changzhou2007-11-01

Track The First People's Hospital of Changzhou automatically

Every clearance here is in the API, with alerts when new ones post.